Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model

European Neuropsychopharmacology

Volumn 10, Issue 6, 2000, Pages 429-435

  Cohen, Hagit ^a   Benjamin, Jonathan ^b   Kaplan, Zeev ^a   Kotler, Moshe ^a  

^a MINISTRY OF HEALTH   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

ACTH; Animal model; Anxiety; Anxiety related behavior; Corticosterone; Hypothalamic pituitary adrenal; Ketoconazole; Posttraumatic stress disorders; Prolactin; Steroid; Stress

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; HYDROCORTISONE; KETOCONAZOLE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; STEROIDOGENESIS; STRESS;

ANIMALS; ANXIETY; BODY WEIGHT; DISEASE MODELS, ANIMAL; ENDOCRINE GLANDS; KETOCONAZOLE; MALE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; STEROIDS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0033672955     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00105-X     Document Type: Article

References (67)

1. Lasting effects on rodent anxiety of a single exposure to a cat
2. Blockade of CCK(B) but not CCK(A) receptor before and after the stress of predator exposure prevent lasting increases in anxiety-like behavior: Implication for anxiety associated with posttraumatic stress disorder
3. Adaptation of anterior pituitary hormones to chronic noise stress in male rats
4. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report
5. Dexamethasone for the treatment of depression: A randomized, placebo-controlled, double-blind trail
6. Dissociation between adrenocorticotropin and corticosterone responses to restraint stress after previous exposure to stress
7. 1 agonists in the rat
8. Effect of Ketoconazole on adrenocorticotrophic hormone secretion in vitro and in vivo
9. Symptom profiles of patients with DSM-III anxiety disorders
10. Psychobiologic mechanisms of posttraumatic stress disorder
11. Interaction of CCK-4 induced anxiety and post-cat exposure anxiety in rats
12. CCK-Antagonists in a rat exposed to acute stress: Implication for anxiety association with posttraumatic stress disorder
13. 'Flooding in vivo' during the circadian phase of minimal cortisol secretion: anxiety and therapeutic success without adrenal cortical activation
14. Reduced 5-hydroxytryptamine-dependent behavior in rats following chronic corticosterone treatment
15. The interplay of learning and anxiety in the elevated plus maze
16. The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment
17. The role of C.R.F. in behavioral aspects of stress
18. Effects of various habituation procedures on pituitary-adrenal responsiveness in the mouse
19. Sensitive pituitary-adrenal responsiveness to varying intensities of psychological stimulation
20. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamus-pituitary-adrenocortical axis
21. Central norepinephrine and plasma corticosterone following acute and chronic stressors: influence of social isolation and handling
22. Habituation to repeated stress in stressor specific
23. Effects of chronic stress on plasma corticosterone
24. A neuropsychological hypothesis explaining posttraumatic stress disorders
25. Sustained urinary norepinephrine and epinephrine elevations in post-traumatic stress disorder
26. Corticosteroid therapy in severe illness
27. Regulation of prolactin secretion at the level of the lactotroph
28. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women
29. Social phobia: review of a neglected anxiety disorder
30. Resolved flurometry in immunoassays
31. The classification of phobic disorders
32. Psychoendocrine approaches in stress research
33. Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder
34. Urinary free-cortisol levels in posttraumatic stress disorder patients
35. Adrenal steroid receptors and actions in the nervous system
36. Hormonal responses to fenfluramine in depression and control subjects
37. Antiglucocorticoid therapies in major depression: a review
38. Response to steroid suppression in major depression resistant to antidepressant therapy
39. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy
40. Endocrine and cardiovascular responses during phobic anxiety
41. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsively of central serotonergic function
42. Once bitten, twice shy: beyond the conditioning model of PTSD
43. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related post-traumatic stress disorder
44. High-dose ketoconazole therapy and adrenal and testicular function in human
45. A radioimmunoassay for rat plasma ACTH
46. Antiglucocorticoid treatments in psychiatry
47. Glucorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response
48. Stress downregulates corticosterone receptors in a site specific manner in the brain
49. Hypercortisolism and its possible neural bases
50. Delayed startle sensitization distinguishes rats exposed to one or three stress sessions: further evidence toward an animal model of PTSD
51. Stress-induced changes in glucorticoid receptors: molecular mechanisms and clinical implications
52. Noradrenergic and Serotonergic Function in Posttraumatic Stress Disorder
53. Ketoconazole therapy for atypical depression
54. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulation
55. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression
56. Inescapable shock, neurotransmitters, and addiction to trauma: toward a psychobiology of Posttraumatic Stress Disorder
57. Antiglucocorticoid treatment of depression: double-blind ketoconazole
58. Ketoconazole administration in hypercortisolemic depression
59. Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder
60. Criteria for rationally evaluating animal models of Posttraumatic stress disorder
61. Hypothalamic pituitary adrenal dysfunction in posttraumatic stress disorder
62. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder
63. Increased number of glucocorticoid receptors in post-traumatic stress disorder
64. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans
65. Low urinary cortisol excretion in-patients with posttraumatic stress disorder
66. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis
67. Negative feedback regulation following administration of chronic exogenous corticosterone